BOLT Annual Cash & Cash Equivalents
$10.81 M
+$1.57 M+16.94%
31 December 2023
Summary:
As of January 23, 2025, BOLT annual cash & cash equivalents is $10.81 million, with the most recent change of +$1.57 million (+16.94%) on December 31, 2023. During the last 3 years, it has risen by +$5.27 million (+95.06%). BOLT annual cash & cash equivalents is now -68.96% below its all-time high of $34.83 million, reached on December 31, 2019.BOLT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BOLT Quarterly Cash And Cash Equivalents
$9.37 M
+$3.16 M+51.02%
30 September 2024
Summary:
As of January 23, 2025, BOLT quarterly cash and cash equivalents is $9.37 million, with the most recent change of +$3.16 million (+51.02%) on September 30, 2024. Over the past year, it has increased by +$3.16 million (+51.02%). BOLT quarterly cash and cash equivalents is now -90.19% below its all-time high of $95.48 million, reached on March 31, 2021.BOLT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BOLT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.9% | +51.0% |
| 3 y3 years | +95.1% | +51.0% |
| 5 y5 years | -20.7% | +51.0% |
BOLT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.5% | +16.9% | -78.7% | +119.8% |
| 5 y | 5-year | -69.0% | +95.1% | -90.2% | +119.8% |
| alltime | all time | -69.0% | +95.1% | -90.2% | +119.8% |
Bolt Biotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.37 M(+51.0%) |
| June 2024 | - | $6.20 M(+45.5%) |
| Mar 2024 | - | $4.26 M(-60.6%) |
| Dec 2023 | $10.81 M(+16.9%) | $10.81 M(+18.0%) |
| Sept 2023 | - | $9.16 M(-31.9%) |
| June 2023 | - | $13.45 M(-9.3%) |
| Mar 2023 | - | $14.84 M(+60.5%) |
| Dec 2022 | $9.24 M | $9.24 M(-12.9%) |
| Sept 2022 | - | $10.62 M(-53.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $22.62 M(-48.6%) |
| Mar 2022 | - | $44.02 M(+60.8%) |
| Dec 2021 | $27.38 M(+394.1%) | $27.38 M(+15.8%) |
| Sept 2021 | - | $23.65 M(-59.4%) |
| June 2021 | - | $58.30 M(-38.9%) |
| Mar 2021 | - | $95.48 M(+1622.9%) |
| Dec 2020 | $5.54 M(-84.1%) | $5.54 M(-68.9%) |
| Sept 2020 | - | $17.79 M(-48.9%) |
| Dec 2019 | $34.83 M(+155.4%) | $34.83 M |
| Dec 2018 | $13.63 M | - |
FAQ
- What is Bolt Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Bolt Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Bolt Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BOLT is $10.81 M
What is the all time high annual cash & cash equivalents for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual cash & cash equivalents is $34.83 M
What is Bolt Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BOLT annual cash & cash equivalents has changed by +$1.57 M (+16.94%)
What is Bolt Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BOLT is $9.37 M
What is the all time high quarterly cash and cash equivalents for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly cash and cash equivalents is $95.48 M
What is Bolt Biotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BOLT quarterly cash and cash equivalents has changed by +$3.16 M (+51.02%)